Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-884-0 | CAS number: 128-39-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Genetic toxicity in vitro:
a) Mutagenicity in vitro in bacteria; Salmonella typhimurium strains TA 1535, TA 1537, TA 1538 TA 98 and TA 100; E. coli (WP2 and WP2 uvrA) and Sacharomyces cerevisiae; negative with and without metabolic activation.
b) Gene mutation (mammalian cell gene mutation assay): HGPRT locus in V79 cells Chinese hamster: negative with and without metabolic activation (OECD 476, EPA 40, EEC 87/32)
c) Chromosome aberration test (mammalian chromosome aberration assay): V79 cell of Chinese hamster: negative with and without metabolic activation (OECD 473, EU Method B.10)
d) DNA damage and repair assay, unscheduled DNA synthesis in mammalian cells in vitro; Freshly isolated rat hepatocytes; negative based on inability to produce a mean grain count of five or greater than the vehicle control mean grain count.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1984-08-13 to 1985-01-07
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study followed standard methodology, but not all details of methodology included in report.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: as described in Ames, B.N. et al, Mutation Research 31: pp. 347-364, 1975
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- GLP Regulations stated in Federal Register, Vol. 43, No. 247, 12/22/1978.
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine locus in selected strains
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S-9 fraction
- Test concentrations with justification for top dose:
- 2.5 x 10-2, 5 x 10-3, 2.5 x 10-3, 5 x 10-4, 2.5 x 10-4 mg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: solubility of test article was best in this solvent - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
NUMBER OF REPLICATIONS: three
- Evaluation criteria:
- Positive response would be an increase in mutant colonies greater than three times the rate seen in the solvent control for that test strain. In the case of TA 98, the solvent control test with activation showed a rate below the spontaneous rate and the historical control. For that test, the spontaneous rate was used for comparison rather than the solvent control results.
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: The highest dose rate (2.5 x 10-2 mg/plate) showed cytotoxicity for TA 1535, TA 1537, and TA 100 with and without metabolic activation.
- Vehicle controls validity:
- other: Solvent control data acceptable, except for TA 98 with activation. Mutation rate was below spontaneous and historical control for that test. Spontaneous rate used for comparison in that test.
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
Test article did not induce a dose related increase in mutant colonies in any Salmonella typhimurium strains tested (TA 1535, TA1537, TA98, TA100) with or without metabolic activation. Therefore, AN 701 was not genetically active in the Salmonella/Microsomal Assay. - Executive summary:
Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100 were tested in a plate incorporation Ames test in the presence and absence of metabolic activation (S-9 fraction from livers of rats induced with Arocolor 1254) with test article dissolved in acetone. Dose levels were 2.5 x 10-2, 5 x 10-3, 2.5 x 10-3, 5 x 10-4, 2.5 x 10-4 mg AN 701/plate. An 701 was soluble at all dose levels tested. Each dose was treated in triplicate. An untreated control, solvent control, and positive control (appropriate to the strain and activation state) were tested concurrently. The highest concentration of AN 701 demonstrated toxicity in strains TA 1535, TA 1537, and TA 100 with and without metabolic activation. AN 701 did not induce a dose related increase in mutant colonies in any strains with or without activation.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24/06/1991-11/09/1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Target gene:
- Chinese hamster cell line V79
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: large stocks of the V79 cell line (supplied by LMP, D-6100 Darmstadt, Germany) were stored in liquid nitrogen in the cell bank of CCR. Thawed stock cultures were propagated at 37°C in 80 cm2 plastic flasks (Greiner, D-7443 Frickenhausen, Germany). About 5 x 100000 cells were seeded into each flask with 15 ml of MEM (minimal essential medium, Seromed, D-1000 Berlin Germany), suplemented with 10% fetal calf serum (FCS, Seromed). The cells were subcultured twice weekly. The cells cultures were subcultured at 37°C and 4.5% carbon dioxide atmosphere.
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: no data - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 liver microsomal fraction
- Test concentrations with justification for top dose:
- Pre-experiment:
Without and with S9 mix:
0.1, 1.0, 3.0, 6.0, 10.0, 30.0, 50.0, 100.0 µg/ml
Main test:
Without S9 mix:
18 h: 0.3, 1.0, 3.0, 4.0, 6.0, 10.0 µg/ml
28 h: 3.0, 4.0, 6.0, 10.0 µg/ml
With S9 mix:
18 h: 3.0, 10.0, 30.0, 36.0, 43.0, 50.0 µg/ml
28 h: 30.0, 36.0, 43.0, 50.0 µg/ml - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen according to its solubility properties and its non-toxicity to cells - Untreated negative controls:
- yes
- Remarks:
- culture medium, with and without metabolic activation
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO, with and without metabolic activation
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- two positive control substances
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- Migrated to IUCLID6: without metabolic activation, final concentration: 1.0 mg/ml = 8.0 mM
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- Migrated to IUCLID6: with metabolic activation, final concentration 4.2 µg/ml = 15 µM
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: 3 days old logarithmically growing stock cultures more than 50% confluent were trypsinised at 37°C for approx. 5 min, then enzymatic digestion stopped by adding complete culture medium and single cell suspension was prepared. Complete medium: MEM + 10% FCS. Prior to trypsin treatment cells were rinsed with Ca-Mg-free salt solution containing 200 mg/l EDTA. After 48 h (28 h preparation interval) and 55 h (18 h preparation interval), the medium was replaced with serum-free medium containing the test article, either without S9 mix or with 50 µg/ml S9 mix
DURATION
- Preincubation period: 48 h (28 h preparation interval) and 55 h (18 h preparation interval), then medium was replaced with serum-free medium containing the test article, either without S9 mix or with 50 µg/ml S9 mix
- Exposure duration: 4 h. After 4 h the serum-free medium containing test article was replaced with complete medium after rinsing twice with "saline G"
- Fixation time (start of exposure up to fixation or harvest of cells): 18 h and 28 h after start of the treatment with the test article: 15.5 and 25.5 h after the start of treatment colcemid was added, 2.5 h later cells were treated with hypotonic solution for 20 min at 37°C, then cells were fixed with 3 + 1 absolute methanol + glacial acetic acid.
SPINDLE INHIBITOR (cytogenetic assays): colcemid
STAIN (for cytogenetic assays): after fixation the cells were stained with Giemsa (Merck, D-6100 Darmstadt, Germany)
NUMBER OF REPLICATIONS: the cells were seeded into Quadripem dishes which contain microscopic slides (2 chambers per dish and test group). In each chamber 5 x 10000 - 1 x 100000 cells.
NUMBER OF CELLS EVALUATED: At least 100 well spread metaphases per slide (per culture) were scored for cytogenetic damage on coded slides except the positive control cultures where 25 metaphases were scored. Only metaphases with characteristic chromosome numbers of 22 ± 1 were included in the analysis
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index (% cells in mitosis)
OTHER EXAMINATIONS:
- Determination of polyploidy: The number of polyploid cells (% polyploid metaphases, in the case of this eneuploid cell line polyploid means a near tetraploid karyotype) was scored.
- Other: chromosomal aberration
OTHER:
Acceptability of the assay:
The chromosomal aberration assay is considered acceptable if it meets the following criteria:
a) the number of aberrations found in the negative and/or solvent controls fall within the laboratory historical control data range: 0.00% - 4.00%.
b) the positive control substances should reproduce significant increases in the number of cells with structural chromosome aberrations. - Evaluation criteria:
- A test article is classified as mutagenic if it induces either a concentration-related increase in the number of structural chromosomal aberrations or a significant positive response for at least one of the test points.
A test article producing neither a concentration related increase in the number of structural chromosomal aberrations nor a significant positive response at any one of the test points is considered non-mutagenic in this system.
This can be confirmed by means of the chi-square test. However, both biological and statistical significance should be considered together. - Statistics:
- Biometry
Statistical significance at the five per cent level (p < 0.05) was evaluated by means of the chi-square test. Evaluation was performed only for cells carrying aberrations exclusive gaps. - Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- not determined
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- mitotic index method
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
-
RANGE-FINDING/SCREENING STUDIES:
In the pre-experiment on toxicity (colony forming ability) in the absence and presence of S9 mix after treatment with concentrations higher than 3.0 (without S9 mix) and 30.0 µg/ml (with S9 mix) the colony forming ability was distinctly reduced. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative non-mutagenic in this chromosomal aberration test
In conclusion it can be stated that in the study described and under the experimental conditions reported, the test article did not induced structural chromosome aberrations as determined by the chromosomal aberration test in the V79 Chinese hamster cell line. Therefore, 2,6-bis(1,1-dimethylethyl)-phenol is considered to be non-mutagenic in this chromosomal aberration test. - Executive summary:
The test article 2,6 -bis(1,1 -dimethyethyl)-phenol was assessed for its potential to induce structural chromosome aberrations in V79 cell of Chinese hamster in vitro.
Preparation of chromosomes was done 18 h (low, medium and high concentration range), and 28 h (high concentration range) after start of treatment with the test article. The treatment interval was 4 h.
In each experiment group two parallel cultures were used. Per culture 100 metaphases were scored for structural chromosomal aberrations except the positive control cultures were 25 metaphases were scored.
The following concentrations were evaluated:
Without S9 mix:
18 h: 0.3, 3.0, 6.0, 10.0 µg/ml
28 h: 6.0 µg/ml
With S9 mix:
18 h: 3.0, 30.0, 50.0 µg/ml
28 h: 50.0 µg/ml
The concentration range of the test article applied had been determined in a pre-experiment using the plating efficiency assay as indicator for toxicity response.
Treatment with concentrations higher than 3.0 (without S9 mix) and 30.0 mg/ml (with S9 mix) reduced distinctly the plating efficiency of the V79 cells. Also the mitotic index was reduced in the samples treated with the highest scorable concentration at both fixation intervals except at interval 28 h in the presence of S9 mix.
There was no relevant increase in cells with structural aberrations after treatment with the test article at each fixation interval either without or with metabolic activation by S9 mix.
Appropriate reference mutagens were used as positive controls and showed distinct increases in cells with structural chromosome aberrations.
In conclusion it can be stated that in the study described and under the experimental conditions reported, the test article did not induced structural chromosome aberrations as determined by the chromosomal aberration test in the V79 Chinese hamster cell line. Therefore, 2,6-bis(1,1-dimethylethyl)-phenol is considered to be non-mutagenic in the chromosomal aberration test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15/07/1991-19/08/1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EPA, 40 CFR, Ch.I, part 798, Detection of gene mutation in somatic cells in culture, pp. 717-720 (7-1-86 Edition)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EEC Directive 87/302, L 133, p. 61-63
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- HGPRT
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: large stocks of the V79 cell line (supplied by LMP, D-6100 Darmstadt, Germany) are stored in liquid nitrogen in the cell bank of CCR. Thawed stock cultures are propagated at 37°C in 80 cm2 plastic flasks (Greiner, D-7440 Nürtingen, Germany). About 5 x 100000 cells are seeded into each flask with 15 ml of MEM (minimal essential medium, Seromed, D-1000 Berlin germany), supplemented with 10% foetal calf serum (FCS, Seromed). The cells are subcultured twice weekly. The cells cultures are incubated at 37°C and 4.5% carbon dioxide atmosphere. For the selection of mutants the medium is supplemented with 11 µg/ml thioguanine (Sigma GmbH, D-8024 Deisenhofen, Germany)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: no data - Additional strain / cell type characteristics:
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- liver microsome preparations
- Test concentrations with justification for top dose:
- Pre-experiment for toxicity (colony forming ability):
- Without and with metabolic activation 0.10, 1.00, 3.00, 6.00, 10.00, 30.00, 50.00, 100 µg
Main experiments:
- Without metabolic activation: 0.30, 1.00, 2.00, 4.00, 6.00, 8.00 µg/ml
- With metabolic activation: 3.00, 10.00, 20.00, 30.00, 40.00, 50.00 µg/ml - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO. On the day of the experiment the test article was dissolved in DMSO (Merck, D-6100 Darmstadt, Germany)
- Justification for choice of solvent/vehicle: The solvent was chosen according to its solubility properties and its non-toxicity to cells. - Untreated negative controls:
- yes
- Remarks:
- concurrent
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- two positive control substances
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- Migrated to IUCLID6: Without metabolic activation, final concentration 0.6 mg/ml = 4.8 mM
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- Remarks:
- Migrated to IUCLID6: With metabolic activation, final concentration 3.85 µg/ml = 15.03 µM
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: 2 or 3 days old logarithmically growing stock cultures more than 50% confluent were trypsinized at 37°C for 5 min. Then digestion stopped by adding complete medium and a single cell suspension prepared. Prior to trypsin treatment cells were rinsed with Ca-Mg-free salt solution containing 200 mg/l EDTA. The cell suspension was seeded into plastic culture flasks (Greines, D-7440 Nürtingen, Germany). Approx. 8 x 100000 and 5 x 100 cells, respectively, were seeded in each flask. The medium was MEM with 10% FCS (complete medium)
DURATION
- Preincubation period: After 24 h the medium was replaced with serum-free medium containing the test article, either without S9 mix or with 50 µl/ml S9 mix.
- Exposure duration: After 4 h the treatment medium was replaced with normal medium after rinsing twice with "saline G".
Experimental Scheme:
Segment a) Procedure for determination of toxicity
Segment b) Procedure for determination of mutation rate
Day 1: subculturing of a log-phase culture
a) About 500 cells in 5 ml medium/25 cm2-plastic-flask for plating efficiency; in duplicate per experimental point.
b) 8 x 100000 cells in 30 ml medium/175 cm2-plastic flask for the mutagenicity test, 1 flask per experimental poit
Day 2: treatement of a) and b)
Experiment 1
Day 5: subculturing of b) in 175 cm2-plastic-flasks or
experiment 2
Day 6: see day 5
Day 8: fixation and staining of colonies in a)-flasks = plating efficiency and concentration relationship
Day 9: subculturing of b) in five 80 cm2-plastic-flasks containing selective medium: mutant selection (about 3-5 x 100000 cell/flask); subculturing of b) in two 25 cm2-flasks for plating efficiency (about 500 cells/flask)
Day 16: Fixation and staining of colonies in b) - derived flasks seeded on day 9 (plating efficiency)
Day 17: Fixation and staining of colonies in b) - derived flasks seeded on day 9 (mutant selection)
SPINDLE INHIBITOR (cytogenetic assays):
STAIN (for cytogenetic assays): 10 % methylene blue in 0.01 % KOH solution (E. Merck, D-6100 Darmstadt, Germany). The stained colonies with more than 50 cells were counted with a preparation microscope (Nikon, D-4000 Düsseldorf, Germany) - Evaluation criteria:
- A test article is classified positive if it induces either a significant concentration-related increase in the mutant frequency or a reproducible and significant positive response for at least one of the test points.
A test article producing neither a significant concentration related increase in the mutant frequency nor a significant and reproducible positive response at any one of the test points is considered non-mutagenic in this system.
A significant response is described as follows:
The test article is classified as mutagenic if it induces reproducibly with at least one of the concentrations a mutation frequency that is three times higher than the spontaneous mutation frequency in the experiment.
The test article is classified as mutagenic if there is a reproducible concentration - related increase in the mutation frequency. Such evaluation may be considered independently of an enhancement factor for induced mutants.
However, in a case by case evaluation this decision depends on the level of the corresponding negative control data. If there is by chance a low spontaneous mutation rate as compared to the range normally found (5-45 mutants per 1000000 cells) a seemingly concentration-related increase of the mutations within this range will be regarded as to be irrelevant. - Statistics:
- Biometry
Since the distribution of mutant cells does not follow known statistical models, an adequate statistical method is not available. - Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not determined
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative non mutagenic in this HGPRT assay
In conclusion can be stated that during the described mutagenicity test and under the experimental conditions reported the test article did not induce point mutations at the HGPRT locus in V79 cells. - Executive summary:
The study was performed to investigate the potential of 2,6 -bis(1,1 -dimethyethyl)-phenol to induce gene mutations at the HGPRT locus in V79 cells of the Chinese hamster in vitro.
The assay was performed in two independent experiments, using identical procedures, both with and without liver microsomal activation.
The test article was tested with the following concentrations:
Experiment I and II:
Without S9 mix: 0.3, 1 -0, 2.0, 4.0, 6.0*, and 8.0 µg/ml
With S9 mix: 3.0, 10.0, 20.0*, 30.0, 40.0, 50.0 µg/ml
* culture was not continued in experiment I and II
According to the pre-experiment for toxicity the concentration ranges were selected to yield concentration related toxic effects. In the first experiment the highest concentration produced a low level of survival and the survival at the lowest concentration was approximately in the range of the negative control.
At the highest investigated concentration no relevant increase in mutant colony numbers was obtained in two independent experiments.
Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies.
In conclusion it can be stated that during the described mutagenecity test and under the experimental conditions reported the test article did not induce point mutations at the HGPRT locus in V79 cells.
Referenceopen allclose all
Mutant colony data for Salmonella typhimurium Ames test for AN 701
Strain |
Activation |
Solvent Control |
Positive Control |
2.5 x 10-2 mg/plate |
5 x 10-3 mg/plate |
2.5 x 10 -3 mg/plate |
5 x 10-4 mg/plate |
2.5 x 10 -4 mg/plate |
TA1535 |
- + |
6 4 |
35* 28* |
6 4 |
7 5 |
4 5 |
6 8 |
8 8 |
TA1537 |
- + |
6 9 |
116* 718* |
6 10 |
7 10 |
10 10 |
9 8 |
8 7 |
TA98 |
- + |
9 15** |
275* 628 |
12 9 |
11 9 |
21 17 |
24 19 |
17 12 |
TA100 |
- + |
89 98 |
3175* TNTC* |
110 111 |
110 104 |
116 111 |
107 113 |
95 100 |
* > 3 times solvent control
** Spontaneous rate
TNTC too numerous to count
Pre-experiment for toxicity:
Table 1: Plating Efficiency Assay (PE) without metabolic activation. Per flask 495 cells were seeded
Conc. Per ml |
Colonies counted |
mean |
PE% relative |
|
Flask I |
Flask II |
|||
Negative control |
301 |
248 |
274.5 |
|
Solvent control (DMSO) |
280 |
271 |
275.5 |
100.0 |
0.1µg |
266 |
291 |
278.5 |
101.1 |
1.0µg |
221 |
259 |
240.0 |
87.1 |
3.0µg |
288 |
300 |
294.0 |
106.7 |
6.0µg |
2 |
9 |
5.5 |
2.0 |
10.0µg |
0 |
0 |
0.0 |
0.0 |
30.0µg |
0 |
0 |
0.0 |
0.0 |
50.0µg |
0 |
0 |
0.0 |
0.0 |
100µg |
0 |
0 |
0.0 |
0.0 |
Table 2: Plating Efficiency Assay (PE) with metabolic activation. Per flask 495 cells were seeded
Conc. Per ml |
Colonies counted |
mean |
PE% relative |
|
Flask I |
Flask II |
|||
Negative control |
309 |
309 |
309.0 |
|
Solvent control (DMSO) |
299 |
271 |
285.0 |
100.0 |
0.1µg |
321 |
287 |
304.0 |
106.7 |
1.0µg |
313 |
281 |
297.0 |
104.2 |
3.0µg |
282 |
302 |
292.0 |
102.5 |
6.0µg |
301 |
299 |
300.0 |
105.3 |
10.0µg |
256 |
284 |
270.0 |
94.7 |
30.0µg |
320 |
279 |
299.5 |
105.1 |
50.0µg |
0 |
0 |
0.0 |
0.0 |
100µg |
0 |
0 |
0.0 |
0.0 |
Main study: In the main experiment the mitotic index was reduced after treatment with the highest scorable concentration in the absence and presence of S9 mix except at interval 28 h in the presence of S9 mix. Both, in the absence and presence of S9 mix the test article did not increase the frequency of cells with aberrations at any fixation interval to a biologically relevant extend. The aberration rates of the cells after treatment with the test article (0.5% - 3.0%) were in or near to the range of the control values: 0.0% - 2.0%). At fixation interval 18h, in the absence of S9 mix after treatment with 10.0 µg/ml, 3 cells were observed carrying exchanges and no cells with exchanges in the corresponding solvent control. However, at interval 28h a similar number of exchanges (2) were found in the control cultures (with S9 mix). Therefore, this effect observed in the samples treated with the test article can be regarded as being biologically not relevant. Due to relative high toxicity found in one of the replicates in this test group an additional sample were evaluated treated with 6.0 µg/ml. In this sample, no evidence of a clastogenic potential was observed. Table 4 shows the occurrence of polyploid metaphases. No relevant deviation from the control data was found after treatment with the test article.
EMS (1.0 mg/ml) nad CPA (4.2 µg/ml) were used as positive controls and showed distinct increases in cells with structural chromosome aberrations.
Table 3a: mitotic index (18 h)
Test group |
Conc. Per ml |
S9 mix |
Fixation interval (h) |
Mitotic index per cent* slide |
Abs. |
Rel. |
|
1 |
2 |
||||||
Negative control |
0.0µg |
- |
18 |
21.0 |
19.2 |
20.1 |
100.0 |
Solvent control DMSO |
1.0% |
- |
18 |
16.1 |
13.3 |
14.7 |
100.0 |
Positive control EMS |
1.0 mg |
- |
18 |
12.3 |
13.3 |
12.8 |
63.8 |
Test article |
0.3µg |
- |
18 |
26.8 |
18.6 |
22.7 |
154.4 |
Test article |
1.0µg |
- |
18 |
14.6 |
17.4 |
16.0 |
108.8 |
Test article |
3.0µg |
- |
18 |
17.1 |
19.6 |
18.4 |
125.2 |
Test article |
4.0µg |
- |
18 |
14.8 |
14.4 |
14.6 |
99.3 |
Test article |
6.0µg |
- |
18 |
5.7 |
5.7 |
5.7 |
38.8 |
Test article |
10.0µg |
- |
18 |
7.4 |
0.0 |
3.7 |
25.2 |
Negative control |
0.0µg |
+ |
18 |
18.4 |
19.2 |
18.8 |
100.0 |
Solvent control DMSO |
1.0 % |
+ |
18 |
16.2 |
18.8 |
17.5 |
100.0 |
Positive control CPA |
4.2µg |
+ |
18 |
4.4 |
8.6 |
6.5 |
34.6 |
Test article |
3.0µg |
+ |
18 |
21.4 |
13.4 |
17.4 |
99.4 |
Test article |
10.0µg |
+ |
18 |
11.7 |
28.7 |
20.2 |
115.4 |
Test article |
30.0µg |
+ |
18 |
26.2 |
19.3 |
22.8 |
130.3 |
Test article |
36.0µg |
+ |
18 |
18.3 |
8.9 |
13.6 |
77.7 |
Test article |
43.0µg |
+ |
18 |
14.2 |
14.8 |
14.5 |
82.9 |
Test article |
50.0µg |
+ |
18 |
1.6 |
5.0 |
3.3 |
18.9 |
* the mitotic index was determined in 1000 cells from each of the two slides per test group
Table 3b: mitotic index (28 h)
Test group |
Conc. Per ml |
S9 mix |
Fixation interval (h) |
Mitotic index per cent* slide |
Abs. |
Rel. |
|
1 |
2 |
||||||
Solvent control DMSO |
1.0% |
- |
28 |
14.9 |
13.3 |
14.6 |
100.0 |
Test article |
3.0µg |
- |
28 |
10.0 |
13.5 |
11.8 |
61.0 |
Test article |
4.0µg |
- |
28 |
6.3 |
12.2 |
9.3 |
63.7 |
Test article |
6.0µg |
- |
28 |
9.0 |
5.6 |
7.3 |
79.5 |
Test article |
10.0µg |
- |
28 |
0.0 |
1.9 |
1.0 |
6.8 |
Solvent control DMSO |
1.0 % |
+ |
28 |
13.5 |
10.9 |
12.2 |
100.0 |
Test article |
30.0µg |
+ |
28 |
14.0 |
16.6 |
15.3 |
96.7 |
Test article |
36.0µg |
+ |
28 |
10.2 |
9.6 |
9.9 |
81.1 |
Test article |
43.0µg |
+ |
28 |
13.5 |
14.3 |
13.9 |
113.9 |
Test article |
50.0µg |
+ |
28 |
13.0 |
13.4 |
13.2 |
108.2 |
* the mitotic index was determined in 1000 cells from each of the two slides per test group
Table 4: number of polyploid cells
Test group |
Conc. Per ml |
S9 mix |
Fixation interval (h) |
Polyploid cells* slide |
Total |
mean |
|
1 |
2 |
||||||
Negative control |
0.0µg |
- |
18 |
1.0 |
3.0 |
4.0 |
2.0 |
Solvent control DMSO |
1.0% |
- |
18 |
5.0 |
4.0 |
9.0 |
4.5 |
Positive control EMS |
1.0 mg |
- |
18 |
3.0 |
2.0 |
5.0 |
2.5 |
Test article |
0.3µg |
- |
18 |
2.0 |
6.0 |
8.0 |
4.0 |
Test article |
3.0µg |
- |
18 |
4.0 |
3.0 |
7.0 |
3.5 |
Test article |
6.0µg |
- |
18 |
2.0 |
6.0 |
8.0 |
4.0 |
Test article |
10.0µg |
- |
18 |
6.0 |
n.s. |
6.0 |
6.0 |
Negative control |
0.0µg |
+ |
18 |
3.0 |
2.0 |
5.0 |
2.5 |
Solvent control DMSO |
1.0 % |
+ |
18 |
0.0 |
4.0 |
4.0 |
2.0 |
Positive control CPA |
4.2µg |
+ |
18 |
2.0 |
1.0 |
3.0 |
1.5 |
Test article |
3.0µg |
+ |
18 |
1.0 |
6.0 |
7.0 |
3.5 |
Test article |
30.0µg |
+ |
18 |
1.0 |
1.0 |
2.0 |
1.0 |
Test article |
50.0µg |
+ |
18 |
12.0 |
2.0 |
4.0 |
2.0 |
Solvent control |
0.0µg |
- |
28 |
4.0 |
5.0 |
9.0 |
4.5 |
Test article |
6.0µg |
- |
28 |
5.0 |
7.0 |
12.0 |
6.0 |
Solvent control |
0.0µg |
+ |
28 |
1.0 |
4.0 |
5.0 |
2.5 |
Test article |
50.0µg |
+ |
28 |
3.0 |
3.0 |
6.0 |
3.0 |
*the number of polyploidy cells was determined in 100 cells from each of the two slides per test group.
n.s. = not scorable due to low metaphase number
Table 21: Mutagenicity data
Fixation interval: 18 h after start of treatment
Test group |
Number of cells analysed |
Conc. Per ml (µg)
|
S9 mix |
Per cent aberrant cells |
||
incl. gaps |
Excl. gaps |
exchanges |
||||
Negative control |
200 |
0.0 |
- |
2.00 |
1.00 |
0.00 |
Solvent control |
200 |
0.0 |
- |
2.00 |
1.00 |
0.00 |
Positive control EMS |
50 |
1.0 |
- |
16.00 |
14.00 |
10.00 |
Test article |
200 |
0.3 |
- |
1.50 |
0.50 |
0.50 |
Test article |
200 |
3.0 |
- |
1.00 |
1.00 |
1.00 |
Test article |
200 |
6.0 |
- |
1.50 |
0.50 |
0.00 |
Test article |
200* |
10.0 |
+ |
4.00 |
3.00 |
1.50 |
Negative control |
200 |
0.0 |
+ |
2.50 |
0.50 |
0.00 |
Solvent control |
200 |
0.0 |
+ |
3.50 |
1.50 |
0.50 |
Positive control CPA |
50 |
4.2 |
+ |
42.00 |
42.00 |
20.00 |
Test article |
200** |
3.0 |
+ |
0.50 |
0.50 |
0.00 |
Test article |
200 |
30.0 |
+ |
1.50 |
1.00 |
0.00 |
Test article |
200 |
50.0 |
+ |
3.50 |
1.50 |
0.50 |
*200 metaphases were scored on slide 1 due to low metaphase number on slide 2
** 200 metaphases were scored on slide 1 due to poor spreading quality of metaphases on slide 2
Table 22: Mutagenicity data
Fixation interval: 28 h after start of the treatment
Test group |
Number of cells analysed |
Conc. Per ml (µg)
|
S9 mix |
Per cent aberrant cells |
||
incl. gaps |
Excl. gaps |
exchanges |
||||
Solvent control |
200 |
0.0 |
- |
2.00 |
0.00 |
0.00 |
Test article |
200 |
6.0 |
- |
3.00 |
0.50 |
0.50 |
Solvent control |
200 |
0.0 |
+ |
4.00 |
2.00 |
1.00 |
Test article |
200 |
50.0 |
+ |
1.00 |
1.00 |
0.50 |
Pre-experiment for toxicity
(the results were obtained from CCR Project 243628, Chromosome aberration)
Plating Efficiency Assay without metabolic activation, 495 single cells were seeded into each flask
Conc. Per ml |
Colonies counted |
mean |
PE% relative |
|
Flask I |
Flask II |
|||
Negative control |
301 |
248 |
274.5 |
|
Solvent control (DMSO) |
280 |
271 |
275.5 |
100.0 |
0.1µg |
266 |
291 |
278.5 |
101.1 |
1.0µg |
221 |
259 |
240.0 |
87.1 |
3.0µg |
288 |
300 |
294.0 |
106.7 |
6.0µg |
2 |
9 |
5.5 |
2.0 |
10.0µg |
0 |
0 |
0.0 |
0.0 |
30.0µg |
0 |
0 |
0.0 |
0.0 |
50.0µg |
0 |
0 |
0.0 |
0.0 |
100µg |
0 |
0 |
0.0 |
0.0 |
Plating Efficiency Assay with metabolic activation, 495 single cells were seeded into each flask
onc. Per ml |
Colonies counted |
mean |
PE% relative |
|
Flask I |
Flask II |
|||
Negative control |
309 |
309 |
309.0 |
|
Solvent control (DMSO) |
299 |
271 |
285.0 |
100.0 |
0.1µg |
321 |
287 |
304.0 |
106.7 |
1.0µg |
313 |
281 |
297.0 |
104.2 |
3.0µg |
282 |
302 |
292.0 |
102.5 |
6.0µg |
301 |
299 |
300.0 |
105.3 |
10.0µg |
256 |
284 |
270.0 |
94.7 |
30.0µg |
320 |
279 |
299.5 |
105.1 |
50.0µg |
0 |
0 |
0.0 |
0.0 |
100µg |
0 |
0 |
0.0 |
0.0 |
The test article was tested in experiment I (without S9 mix) and II (with S9 mix).
In the first experiment the plating efficiency was reduced at the highest concentration but in the second experiment no decrease of the plating efficiency was observed up to the highest concentration (see tables I and IV), PE% relative).
Table I: toxicity data, experiment I
Column |
Conc. Per ml |
S9 mix |
Number of cells per flask* |
PE%** absolute |
PE%*** relative |
|||
seeded |
found |
mean |
||||||
I/II |
I |
II |
|
|||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
|
Negative control |
0.00µg |
- |
497 |
298 |
299 |
298.5 |
60.1 |
100.0 |
Solvent control DMSO |
0.00µg |
- |
497 |
260 |
260 |
260.0 |
52.3 |
100.0 |
Positive control EMS |
0.60µg |
- |
497 |
197 |
160 |
178.5 |
35.9 |
59.8 |
Test article |
0.30µg |
- |
497 |
266 |
257 |
261.5 |
52.6 |
100.6 |
Test article |
1.00µg |
- |
497 |
359 |
232 |
245.5 |
49.4 |
94.4 |
Test article |
2.00µg |
- |
497 |
258 |
252 |
255.0 |
51.3 |
98.1 |
Test article |
4.00µg |
- |
497 |
309 |
272 |
290.5 |
58.5 |
111.7 |
Test article |
6.00µg |
- |
497 |
220 |
226 |
223.0 |
44.9 |
85.8 |
Test article |
8.00 µg |
- |
497 |
13 |
20 |
16.5 |
3.3 |
6.3 |
Negative control |
0.00µg |
+ |
497 |
307 |
305 |
306.0 |
61.6 |
100.0 |
Solvent control DMSO |
0.00µg |
+ |
497 |
246 |
248 |
247.0 |
49.7 |
100.0 |
Positive control DMBA |
3.85µg |
+ |
497 |
270 |
249 |
259.5 |
52.2 |
105.1 |
Test article |
3.00µg |
+ |
497 |
256 |
271 |
263.5 |
53.0 |
86.1 |
Test article |
10.00µg |
+ |
497 |
227 |
234 |
230.5 |
46.4 |
75.3 |
Test article |
20.00µg |
+ |
497 |
253 |
253 |
253.0 |
50.9 |
82.7 |
Test article |
30.00µg |
+ |
497 |
244 |
259 |
251.5 |
50.6 |
82.2 |
Test article |
40.00µg |
+ |
497 |
258 |
299 |
278.5 |
56.0 |
91.0 |
Test article |
50.00µg |
+ |
497 |
217 |
240 |
228.5 |
46.0 |
74.7 |
*only colonies with more than 50 cells 7 days after seeding were scored
** PE absolute (value column 6/value column 3 x 100)
***PE relative (value column 6/value column 6 of corresponding control x 100)
Table II: Mutagenicity data, experiment I (part 1: cell survival)
Column |
Conc. Per ml |
S9 mix |
Number of cells per flask* |
Factor** calculated |
Cells seeded |
Cells*** survived |
|||||
seeded |
found |
mean |
|
|
|
||||||
I/II |
I |
II |
|
||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|||
Negative control |
0.00µg |
- |
556 |
402 |
367 |
384.5 |
0.69 |
387000 |
267030 |
||
Negative control DMSO |
0.00µg |
- |
474 |
391 |
432 |
411.5 |
0.87 |
453000 |
394110 |
||
Positive control EMS |
0.60µg |
- |
567 |
457 |
431 |
444.0 |
0.78 |
375000 |
292500 |
||
Test article |
0.30µg |
- |
486 |
380 |
410 |
395.0 |
0.81 |
450000 |
364500 |
||
Test article |
1.00µg |
- |
526 |
300 |
335 |
317.5 |
0.60 |
480000 |
288000 |
||
Test article |
2.00µg |
- |
Culture was not continued |
|
|
|
|||||
Test article |
4.00µg |
- |
539 |
321 |
333 |
327.0 |
0.61 |
426000 |
259860 |
||
Test article |
6.00µg |
- |
Culture was not continued |
|
|
|
|||||
Test article |
8.00 µg |
- |
530 |
335 |
363 |
349.0 |
0.66 |
372000 |
245520 |
||
Negative control |
0.00µg |
+ |
568 |
380 |
373 |
376.5 |
0.66 |
450000 |
297000 |
||
Negative control DMSO |
0.00µg |
+ |
537 |
357 |
344 |
350.5 |
0.65 |
432000 |
280800 |
||
Positive control DMBA |
3.85µg |
+ |
479 |
307 |
323 |
315.0 |
0.66 |
423000 |
279180 |
||
Test article |
3.00µg |
+ |
579 |
374 |
331 |
352.5 |
0.61 |
402000 |
245220 |
||
Test article |
10.00µg |
+ |
461 |
324 |
330 |
327.0 |
0.71 |
450000 |
319500 |
||
Test article |
20.00µg |
+ |
Culture was not continued |
|
|
||||||
Test article |
30.00µg |
+ |
497 |
316 |
315 |
315.5 |
0.63 |
435000 |
274050 |
||
Test article |
40.00µg |
+ |
Culture was not continued |
|
|
|
|||||
Test article |
50.00µg |
+ |
486 |
264 |
297 |
280.5 |
0.58 |
435000 |
252300 |
*only colonies with more than 50 cells 7 days after seeding in normal medium were scored
** factor calculated (value column 6/value column 3)
***cells survived after plating in TG containing medium (value column 8 x value column 7)
Table III: Mutagenicity data, experiment I (part 2: mutation rates)
Column |
Conc per ml |
S9 mix |
Number of mutant colonies per flask* found after plating in TG medium |
Standard deviation |
Mutant** colonies per 106cells |
|||||
I |
II |
III |
IV |
V |
mean |
|||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
|
Negative control |
0.00µg |
- |
7 |
1 |
11 |
6 |
4 |
5.8 |
3.7 |
21.7 |
Negative control DMSO |
0.00µg |
- |
5 |
1 |
3 |
4 |
3 |
3.2 |
1.5 |
8.1 |
Positive control EMS |
0.60µg |
- |
103 |
83 |
93 |
91 |
80 |
90.0 |
9.1 |
307.7 |
Test article |
0.30µg |
- |
14 |
16 |
18 |
11 |
8 |
13.4 |
4.0 |
36.8 |
Test article |
1.00µg |
- |
3 |
6 |
7 |
4 |
10 |
6.0 |
2.7 |
20.8 |
Test article |
2.00µg |
- |
Culture was not continued |
|
|
|
|
|||
Test article |
4.00µg |
- |
4 |
8 |
8 |
6 |
9 |
7.0 |
2.0 |
26.9 |
Test article |
6.00µg |
- |
Culture was not continued |
|
|
|
|
|||
Test article |
8.00 µg |
- |
10 |
3 |
6 |
4 |
2 |
5.0 |
3.2 |
20.4 |
Negative control |
0.00µg |
+ |
5 |
8 |
5 |
8 |
11 |
7.4 |
2.5 |
24.9 |
Negative control DMSO |
0.00µg |
+ |
14 |
11 |
18 |
11 |
15 |
13.8 |
2.9 |
49.1 |
Positive control DMBA |
3.85µg |
+ |
131 |
123 |
126 |
139 |
101 |
124.0 |
14.2 |
444.2 |
Test article |
3.00µg |
+ |
4 |
10 |
5 |
12 |
10 |
8.2 |
3.5 |
33.4 |
Test article |
10.00µg |
+ |
5 |
6 |
8 |
3 |
5 |
5.4 |
1.8 |
16.9 |
Test article |
20.00µg |
+ |
Culture was not continued |
|
|
|
|
|||
Test article |
30.00µg |
+ |
6 |
5 |
6 |
8 |
8 |
6.6 |
1.3 |
24.1 |
Test article |
40.00µg |
+ |
Culture was not continued |
|
|
|
|
|||
Test article |
50.00µg |
+ |
5 |
9 |
8 |
11 |
5 |
7.6 |
2.6 |
30.1 |
*only colonies with more than 50 cells 8 days after seeding in TG medium were scored
**value column 8 x106/value column 9 (table I)
Table IV: toxicity data, experiment II
Column |
Conc. Per ml |
S9 mix |
Number of cells per flask* |
PE%** absolute |
PE%*** relative |
|||
seeded |
found |
mean |
||||||
I/II |
I |
II |
|
|||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
|
Negative control |
0.00µg |
- |
497 |
295 |
296 |
295.5 |
59.5 |
100.0 |
Solvent control DMSO |
0.00µg |
- |
497 |
289 |
262 |
275.5 |
55.4 |
100.0 |
Positive control EMS |
0.60µg |
- |
497 |
291 |
240 |
265.5 |
53.4 |
89.8 |
Test article |
0.30µg |
- |
497 |
353 |
277 |
315.0 |
63.4 |
114.3 |
Test article |
1.00µg |
- |
497 |
346 |
342 |
344.0 |
69.2 |
124.9 |
Test article |
2.00µg |
- |
497 |
280 |
287 |
283.5 |
57.0 |
102.9 |
Test article |
4.00µg |
- |
497 |
276 |
322 |
299.0 |
60.2 |
108.5 |
Test article |
6.00µg |
- |
497 |
371 |
341 |
356.0 |
71.6 |
129.2 |
Test article |
8.00 µg |
- |
497 |
310 |
315 |
312.5 |
62.9 |
113.4 |
Negative control |
0.00µg |
+ |
497 |
325 |
314 |
319.5 |
64.3 |
100.0 |
Solvent control DMSO |
0.00µg |
+ |
497 |
317 |
297 |
307.0 |
61.8 |
100.0 |
Positive control DMBA |
3.85µg |
+ |
497 |
191 |
206 |
198.5 |
39.9 |
64.7 |
Test article |
3.00µg |
+ |
497 |
303 |
284 |
293.5 |
59.1 |
91.9 |
Test article |
10.00µg |
+ |
497 |
315 |
267 |
291.0 |
58.6 |
91.1 |
Test article |
20.00µg |
+ |
497 |
299 |
297 |
298.0 |
60.0 |
93.3 |
Test article |
30.00µg |
+ |
497 |
289 |
303 |
296.0 |
59.6 |
92.6 |
Test article |
40.00µg |
+ |
497 |
282 |
272 |
277.0 |
55.7 |
86.7 |
Test article |
50.00µg |
+ |
497 |
263 |
294 |
278.5 |
56.0 |
87.2 |
*only colonies with more than 50 cells 7 days after seeding were scored
** PE absolute (value column 6/value column 3 x 100)
***PE relative (value column 6/value column 6 of corresponding control x 100)
Table V: mutagenicity data experiment II (part 1: cell survival)
Column |
Conc. Per ml |
S9 mix |
Number of cells per flask* |
Factor** calculated |
Cells seeded |
Cells*** survived |
|||||
seeded |
found |
mean |
|
|
|
||||||
I/II |
I |
II |
|
||||||||
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
|||
Negative control |
0.00µg |
- |
487 |
512 |
452 |
482.0 |
0.99 |
392000 |
388080 |
||
Negative control DMSO |
0.00µg |
- |
450 |
367 |
420 |
393.5 |
0.87 |
435000 |
378450 |
||
Positive control EMS |
0.60µg |
- |
515 |
434 |
448 |
441.0 |
0.86 |
444000 |
381840 |
||
Test article |
0.30µg |
- |
497 |
398 |
400 |
399.0 |
0.80 |
426000 |
340800 |
||
Test article |
1.00µg |
- |
476 |
375 |
401 |
388.0 |
0.82 |
498000 |
408360 |
||
Test article |
2.00µg |
- |
Culture was not continued |
|
|
|
|||||
Test article |
4.00µg |
- |
452 |
386 |
421 |
403.5 |
0.89 |
492000 |
437880 |
||
Test article |
6.00µg |
- |
Culture was not continued |
|
|
|
|||||
Test article |
8.00 µg |
- |
480 |
446 |
460 |
453.0 |
0.94 |
435000 |
408900 |
||
Negative control |
0.00µg |
+ |
505 |
377 |
397 |
387.0 |
0.77 |
369000 |
284130 |
||
Negative control DMSO |
0.00µg |
+ |
492 |
338 |
436 |
387.0 |
0.79 |
306000 |
241740 |
||
Positive control DMBA |
3.85µg |
+ |
494 |
333 |
334 |
333.5 |
0.68 |
396000 |
269280 |
||
Test article |
3.00µg |
+ |
495 |
369 |
393 |
381.0 |
0.77 |
402000 |
309540 |
||
Test article |
10.00µg |
+ |
510 |
346 |
308 |
327.0 |
0.64 |
378000 |
241920 |
||
Test article |
20.00µg |
+ |
Culture was not continued |
|
|
||||||
Test article |
30.00µg |
+ |
533 |
245 |
283 |
264.0 |
0.50 |
387000 |
193500 |
||
Test article |
40.00µg |
+ |
Culture was not continued |
|
|
|
|||||
Test article |
50.00µg |
+ |
493 |
407 |
367 |
387.0 |
0.78 |
384000 |
299520 |
*only colonies with more than 50 cells 7 days after seeding in normal medium were scored
** factor calculated (value column 6/value column 3)
***cells survived after plating in TG containing medium (value column 8 x value column 7)
See Table VI in overall remarks.
Taking into account the mutation rates found in the groups treated with the test article compared to the negative and solvent controls it can be concluded that no biologically relevant increase of point mutations was observed. The test article did not induce reproducible concentration-related increase in the mutant colony numbers. The mutant values of the groups treated with the test article were in the range of the negative controls.
In this study in both experiment (with and without S9 mix) the range of the negative controls was from 0.7 up to 49.1 mutants per 1000000 cells, the range of the groups treated with the test article was from 0.5 up to 36.8 mutants per 1000000 cells.
EMS (0.6 mg(ml) and DMBA (3.85 µg/ml) were used as positive controls and showed a distinct increase in induced mutant colonies.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Genetic toxicity in vitro:
Mutagenicity in vitro in bacteria
Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100 were tested in a plate incorporation Ames test (in the presence and absence of metabolic activation (S-9 fraction from livers of rats induced with Arocolor 1254) with 2,6-di-tert-butylphenol (AN 701) dissolved in acetone. Dose levels were 2.5 x 10-2, 5 x 10-3, 2.5 x 10-3, 5 x 10-4, 2.5 x 10-4mg AN 701/plate. AN 701 was soluble at all dose levels tested. Each dose was treated in triplicate. An untreated control, solvent control, and positive control (appropriate to the strain and activation state) were tested concurrently. The highest concentration of AN 701 demonstrated toxicity in strains TA 1535, TA 1537, and TA 100 with and without metabolic activation. AN 701 did not induce a dose related increase in mutant colonies in any strains with or without activation.
Test method and results:
The bacterial reverse mutation assay (Ames test) was conducted as described in Ames, B.N. et al, Mutation Research 31: pp. 347-364, 1975, at the following concentration levels:-
2.5 x 10-2, 5 x 10-3, 2.5 x 10-3, 5 x 10-4, 2.5 x 10-4mg AN 701/plate
Species/strain -S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation -with and without
Test system -all strains/cell types tested
Genotoxicity -negative
Cytotoxicity -other: The highest dose rate (2.5 x 10-2 mg/plate) showed cytotoxicity for TA 1535, TA 1537, and TA 100 with and without metabolic activation.
Vehicle controls valid -other: Solvent control data acceptable, except for TA 98 with activation. Mutation rate was below spontaneous and historical control for that test. Spontaneous rate used for comparison in that test.
Positive controls valid -yes
Test article did not induce a dose related increase in mutant colonies in any Salmonella typhimurium strains tested (TA 1535, TA1537, TA98, TA100) with or without metabolic activation. Therefore, AN 701 was not genetically active in the Salmonella/Microsomal Assay.
Gene mutation (mammalian cell gene mutation assay)
The study was performed to investigate the potential of 2,6 -bis(1,1 -dimethyethyl)-phenol to induce gene mutations at the HGPRT locus in V79 cells of the Chinese hamster in vitro. In conclusion it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test article did not induce point mutations at the HGPRT locus in V79 cells.
Test method and results:
The assay was performed in two independent experiments, using identical procedures, both with and without liver microsomal activation.
The test article was tested with the following concentrations:
Experiment I and II:
Without S9 mix: 0.3, 1.0, 2.0, 4.0, 6.0*, and 8.0 µg/ml
With S9 mix: 3.0, 10.0, 20.0*, 30.0, 40.0, 50.0 µg/ml
* culture was not continued in experiment I and II
According to the pre-experiment for toxicity the concentration ranges were selected to yield concentration related toxic effects. In the first experiment the highest concentration produced a low level of survival and the survival at the lowest concentration was approximately in the range of the negative control.
Up to the highest investigated concentration no relevant increase in mutant colony numbers was obtained in two independent experiments.
Appropriate reference mutagens were used as positive controls and showed a distinct increase in induced mutant colonies.
Chromosome aberration test (mammalian chromosome aberration assay):
The test article 2,6 -bis(1,1-dimethyethyl)-phenol was assessed for its potential to induce structural chromosome aberrations in V79 cell of Chinese hamster in vitro. In conclusion it can be stated that in the study described and under the experimental conditions reported, the test article did not induced structural chromosome aberrations as determined by the chromosomal aberration test in the V79 Chinese hamster cell line. Therefore, 2,6-bis(1,1-dimethylethyl)-phenol is considered to be non-mutagenic in this chromosomal aberration test.
Test method and results:
Preparation of chromosomes was done 18 h (low, medium and high concentration range), and 28 h (high concentration range) after start of treatment with the test article. The treatment interval was 4 h.
In each experiment group two parallel cultures were used. Per culture 100 metaphases were scored for structural chromosomal aberrations except the positive control cultures where 25 metaphases were scored.
The following concentrations were evaluated:
Without S9 mix:
18 h: 0.3, 3.0, 6.0, 10.0µg/ml
28 h: 6.0 µg/ml
With S9 mix:
18 h: 3.0, 30.0, 50.0 µg/ml
28 h: 50.0 µg/ml
The concentration range of the test article applied had been determined in a pre-experiment using the plating efficiency assay as indicator for toxicity response.
Treatment with concentrations higher than 3.0 (without S9 mix) and 30.0 mg/ml (with S9 mix) reduced distinctly the plating efficiency of the V79 cells. Also the mitotic index was reduced in the samples treated with the highest scorable concentration at both fixation intervals except at interval 28 h in the presence of S9 mix.
There was no relevant increase in cells with structural aberrations after treatment with the test article at each fixation interval either without or with metabolic activation by S9 mix.
Appropriate reference mutagens were used as positive controls and showed distinct increases in cells with structural chromosome aberrations.
DNA damage and repair assay, unscheduled DNA synthesis in mammalian cells in vitro
Freshly isolated rat hepatocytes were treated with 20 µl test article solution per 2 ml media to give concentrations of AN 701 (2,6 -DTBP) of 0.05, 0.1, 0.5, 1, 5, 10, 50, 100, 500, and 1000 µg/well. In addition a solvent control (acetone), an untreated control, and a positive control (2 -acetoamidofluorene at 10 -6M) were assessed concurrently. Cytotoxicity was seen at AN 701 concentrations of 50 µg/well and higher. The highest dose scored for AN 701 was 10 µg/ml. Unscheduled DNA repair synthesis was quantified by a net nuclear increase of black silver grains for 25 cells per slide. This value was determined by taking a nuclear count and the average of three adjacent cytoplasmic counts. AN 701 did not cause an increase in mean net nuclear counts over solvent counts at any dose level counted. The number of cells with net nuclear grain counts greater than zero of all scored dose levels was not significantly increased statistically over solvent control. Under the conditions of the test, AN 701 was negative in the Rat Hepatocyte Primary Culture/DNA Repair test based on inability to produce a mean grain count of five or greater than the vehicle control mean grain count, and no statistically increased number of cells with nuclear grain count greater than zero compared to vehicle control.
Test method and results:
Male Fischer 344 rats were obtained from Charles River Breeding Laboratories, and weighed from 150 to 300 grams at the start of the study. Animals were housed at the Louisiana State University School of Veterinary Medicine, Baton Rouge, Louisiana. For recovery of the hepatocytes for the test, the rats were anesthetized by sodium Nembutal injection intraperitoneally. When anesthetized, the liver was perfused with Medium A (0.5 mM EDTA) and Medium B (Collagenase, 100 units/mL), and the livers removed, and the hepatocytes harvested. Freshly isolated rat hepatocytes were then treated with 20 ul of AN 701 at doses of 0.05, 0.1, 0.5, 1, 10, 50, 100, 500, and 1000 ug/well in 2 mL of media. Additionally, an acetone group, an untreated control and a positive control (2 -acetoamidofluorene, 2 -AAF at 10 -6M) were concurrently evaluated. After treatment, hepatocytes were fixed on microscope slides, stained, dipped and developed for assessment of black silver grains in the nuclei. An automatic colony counter was used to evaluate 25 cells for grain counts in the nuclei. Net nuclear count value was determined by taking a nuclear count and the average of three adjacent cytoplasmic counts.
AN 701 treatment did not cause an increase in mean net nuclear count over solvent for any dose level counted. Cytotoxicity was produced at levels of 50 ug/well and higher. Thus, the highest level scored was 10 ug/well.
Waiving argument against an additional Ames-Test with 5 strains
Data basis
The following in vitro genotoxicity tests are currently available in the REACH Registration Dossier of 2,6-bis(1,1-dimethylethyl)-phenol (CAS No 128-39-2, EC No 204-884-0, registration number: 01-2119490822-33-0000) (see http://echa.europa.eu/information-onchemicals/registered-substances):
Genetic toxicity in vitro:
a) Mutagenicity in vitro in bacteria; Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100; negative with and without metabolic activation.
b) Gene mutation (mammalian cell gene mutation assay): HGPRT locus in V79 cells Chinese hamster: negative with and without metabolic activation (OECD 476, EPA 40, EEC 87/32)
c) Chromosome aberration test (mammalian chromosome aberration assay): V79 cell of Chinese hamster: negative with and without metabolic activation (OECD 473, EU Method B.10)
d) DNA damage and repair assay, unscheduled DNA synthesis in mammalian cells in vitro; Freshly isolated rat hepatocytes; negative based on inability to produce a mean grain count of five or greater than the vehicle control mean grain count.
Scientific analysis
The Ames test was conducted in 1985 and was in full compliance to the relevant guideline OECD 471 at that date including GLP compliance. As some details on the methodology were missing in the report a reliability score of 2 was assigned to the test and as the consortium understands, this assignment is not questioned by ECHA. The test reports negative results for all four test strains.
A supporting study is available in literature (Dean et al., 1985), in which 2 -DTBP was tested in Salmonella typhimurium strains TA 1535, TA 1537, TA 1538, TA 98 and TA 100, E. coli (WP2 and WP2 uvrA) and Sacharomyces cerevisae were tested in a pre-incubation and plate incorporation Ames test in the presence and absence of metabolic activation (S-9 fraction from livers of rats induced with Arocolor 1254) with test article dissolved in DMSO. Dose levels were 125, 250, 500, 1000, 2000 and 4000 µg/plate. Each dose was treated at least in triplicate. A solvent control, and positive control (appropriate to the strain and activation state) were tested concurrently. The test item did not induce an increase in mutant colonies in any strains with or without activation.
Conclusion
Firstly in compliance with the standard data requirements a reliable in vitro mammalian cell gene mutation assay and a reliable in vitro chromosome aberration assay are available. As a surplus data from a reliable UDS assay (unscheduled DNA synthesis) in mammalian cells in vitro are presented in the REACH Registration Dossier for 2,6-bis(1,1-dimethylethyl)-phenol (CAS No 128-39-2, EC No 204-884-0, registration number: 01-2119490822-33-0000). It is the consortium's understanding that the reliability of these tests is not questioned by ECHA.
Both the in vitro mammalian cell gene mutation assay as well as the in vitro UDS assay in mammalian cells aim at the same endpoint as the Ames test, which is gene mutation. We regard it as extremely unlikely that the combination of these two test systems is not able to detect a potential genotoxic mechanism that is relevant to humans that could on the other hand be detected by E.coli WP2 strains or S. typhimurium TA102 in the Ames tests. Especially the surplus in vitro UDS assay in mammalian cells is in our eyes very well suited to cover the information gap that stems from the lacking 5th strain in the available Ames test.
In the Guidance on information requirements and Chemical Safety Assessment (Chapter R.7a: Endpoint specific guidance, Version 2.2, August 2013) it is stated: "If negative results are available from an adequate evaluation of genotoxicity from existing data in appropriate test systems, there may be no requirement to conduct additional genotoxicity tests." With regard to the available four reliable in vitro genotoxicity tests the consortium has the opinion that this requirement is fulfilled and that no additional testing is required in order to allow a solid hazard assessment for the genotoxicity potential of 2,6-bis(1,1-dimethylethyl)-phenol (CAS No 128-39-2, EC No 204-884-0, registration number: 01-2119490822-33-0000) that is relevant for humans.
Justification for classification or non-classification
No classification in accordance with EU CLP (Regulation (EC) No. 1272/2008). All in vitro tests are negative.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.